Literature DB >> 9005745

Results of transplanting bone marrow from genetically identical twins into patients with aplastic anemia.

W Hinterberger1, P A Rowlings, M Hinterberger-Fischer, J Gibson, N Jacobsen, J P Klein, H J Kolb, D A Stevens, M M Horowitz, R P Gale.   

Abstract

BACKGROUND: Aplastic anemia is caused by several diverse factors, including a lack of or defective hematopoietic stem cells, immune abnormalities, and disorders of the bone marrow microenvironment. The outcome of transplanting bone marrow from genetically identical twins into patients with aplastic anemia may help define how frequently these factors play a role in this condition.
OBJECTIVE: To determine the outcome of transplanting bone marrow from genetically identical twins into patients with aplastic anemia.
DESIGN: Observational study.
SETTING: 31 centers participating in the international Bone Marrow Transplant Registry. PATIENTS: 40 patients with aplastic anemia who received bone marrow transplants from their genetically identical twins between 1964 and 1992. INTERVENTION: 23 patients received their first bone marrow transplant without pretransplantation conditioning; 17 received it after pretransplantation conditioning with cyclophosphamide alone or combined with other drugs or radiation. Six patients received post-transplantation immunosuppressive therapy with methotrexate, cyclosporine, and corticosteroids, alone or in combination. MEASUREMENTS: Outcomes of transplantation, including hematologic recovery and survival.
RESULTS: Seven of 23 patients who received their first transplant without receiving conditioning had sustained complete hematologic recovery. One of 16 patients who did not have complete recovery after the first transplantation recovered after a second transplantation, which was not preceded by conditioning. The other 15 patients had two to five transplantations that were preceded by conditioning; in 13 patients, sustained bone marrow function was recovered. Twelve of 17 patients whose first transplantation was preceded by conditioning had sustained complete hematologic recovery. The likelihood of hematologic recovery was greater in patients who had conditioning before the first transplantation (P = 0.033). The actuarial 10-year survival rate for the 40 patients was 78% (95% CI, 59% to 92%). The survival rate was higher in patients who did not have conditioning before the first transplantation (patients without conditioning, 87% [range, 65% to 99%]; patients with conditioning, 70% [range, 47% to 89%]; P = 0.037).
CONCLUSIONS: Most patients with aplastic anemia recover bone marrow function after receiving a transplant from a genetically identical twin. Pretransplantation conditioning may increase the chance of bone marrow recovery but does not seem to improve survival.

Entities:  

Mesh:

Year:  1997        PMID: 9005745     DOI: 10.7326/0003-4819-126-2-199701150-00004

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  8 in total

1.  Early and late graft-failure after transplants.

Authors:  R P Gale
Journal:  Bone Marrow Transplant       Date:  2015-11-02       Impact factor: 5.483

2.  Autologous GVHD?

Authors:  F Otegbeye; R P Gale; H M Lazarus
Journal:  Bone Marrow Transplant       Date:  2014-08-04       Impact factor: 5.483

Review 3.  Current concepts in the pathophysiology and treatment of aplastic anemia.

Authors:  Neal S Young; Rodrigo T Calado; Phillip Scheinberg
Journal:  Blood       Date:  2006-06-15       Impact factor: 22.113

4.  Human gingiva tissue-derived MSC ameliorates immune-mediated bone marrow failure of aplastic anemia via suppression of Th1 and Th17 cells and enhancement of CD4+Foxp3+ regulatory T cells differentiation.

Authors:  Jianzhi Zhao; Jingrong Chen; Feng Huang; Julie Wang; Wenru Su; Jianyao Zhou; Quanyin Qi; Fenglin Cao; Baoqing Sun; Zhongmin Liu; Joseph A Bellanti; Songguo Zheng
Journal:  Am J Transl Res       Date:  2019-12-15       Impact factor: 4.060

Review 5.  Biology of BM failure syndromes: role of microenvironment and niches.

Authors:  Sophia R Balderman; Laura M Calvi
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2014-11-18

Review 6.  Pathophysiology and treatment of aplastic anemia.

Authors:  Klaus Geissler
Journal:  Wien Klin Wochenschr       Date:  2003-08-14       Impact factor: 1.704

7.  Syngeneic transplantation in aplastic anemia: pre-transplant conditioning and peripheral blood are associated with improved engraftment: an observational study on behalf of the Severe Aplastic Anemia and Pediatric Diseases Working Parties of the European Group for Blood and Marrow Transplantation.

Authors:  Sabine Gerull; Martin Stern; Jane Apperley; Dietrich Beelen; Lorentz Brinch; Donald Bunjes; Andrew Butler; Arnold Ganser; Ardeshir Ghavamzadeh; Mickey B Koh; Mieczyslaw Komarnicki; Nicolaus Kröger; Johan Maertens; Alexei Maschan; Christina Peters; Montserrat Rovira; Henrik Sengeløv; Gerard Socié; Johanna Tischer; Rosi Oneto; Jakob Passweg; Judith Marsh
Journal:  Haematologica       Date:  2013-07-26       Impact factor: 9.941

8.  A novel autologous stem cell procedure for the treatment of aplastic anaemia using reprogrammed mature adult cells: a pilot study.

Authors:  Ilham Saleh Abuljadayel; Dipika Mohanty; Rajendar K Suri
Journal:  Indian J Med Res       Date:  2012-06       Impact factor: 2.375

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.